Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISRCTN94103375Phase 3Completed
Phase 3, randomised trial in nicotine dependence comparing Varenicline + behavioral support with Placebo + behavioral support (2 arms). Primary endpoint: Continuous abstinence. Started Jan 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ISRCTN94103375.